Viatris (VTRS) Change in Inventory (2020 - 2026)
Viatris' (VTRS) quarterly Change in Inventory came in at $123.0 million in Q1 2026, down 36.5% year-on-year from $193.7 million in Q1 2025, and up 878.48% quarter-over-quarter from -$15.8 million in Q4 2025.
Viatris (VTRS) Change in Inventory (2020 - 2026) Analysis & Trends
Viatris' Change in Inventory history runs 7 years deep, the most recent figure standing at $123.0 million for Q1 2026.
- On a quarterly basis, Change in Inventory fell 36.5% year-over-year to $123.0 million in Q1 2026; TTM through Mar 2026 was $35.7 million, a 93.47% decrease from a year earlier, with the FY2025 full-year figure at $106.4 million, down 85.29% from the prior year.
- Change in Inventory climbed to $123.0 million in Q1 2026 per VTRS's latest filing, from -$15.8 million in the prior quarter.
- Across five years, Change in Inventory topped out at $370.4 million in Q1 2024 and bottomed at -$180.1 million in Q4 2022.
- The 5-year median for Change in Inventory is $127.6 million (2023), against an average of $107.4 million.
- Biggest YoY gain for Change in Inventory was 1578.22% in 2022; the steepest drop was 335.42% in 2022.
- Year by year, Change in Inventory stood at -$180.1 million in 2022, then jumped by 170.85% to $127.6 million in 2023, then slumped by 72.1% to $35.6 million in 2024, then tumbled by 144.38% to -$15.8 million in 2025, then jumped by 878.48% to $123.0 million in 2026.
- Per Business Quant, the three latest VTRS Change in Inventory figures stand at $123.0 million (Q1 2026), -$15.8 million (Q4 2025), and -$110.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.00 Mn |
| Mar 31, 2026 | 123.00 Mn |
| Dec 31, 2025 | -15.80 Mn |
| Dec 31, 2025 | -15.80 Mn |
| Sep 30, 2025 | -110.50 Mn |
| Sep 30, 2025 | -110.50 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Mar 31, 2025 | 193.70 Mn |
| Mar 31, 2025 | 193.70 Mn |
| Dec 31, 2024 | 35.60 Mn |
| Dec 31, 2024 | 35.60 Mn |
| Sep 30, 2024 | 129.00 Mn |
| Sep 30, 2024 | 129.00 Mn |
| Jun 30, 2024 | 188.40 Mn |
| Jun 30, 2024 | 188.40 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Dec 31, 2023 | 127.60 Mn |
| Dec 31, 2023 | 127.60 Mn |